The United States remains one of the most significant contributors to the global Addisons Disease Treatment Market due to its advanced healthcare infrastructure, strong pharmaceutical industry presence, and increasing awareness of rare endocrine disorders. Growing investments in endocrinology research, improved diagnostic capabilities, and favorable reimbursement frameworks have enhanced access...